Resolve360: Reimagining Rehabilitation Through AI and Digital Physiotherapy
November 04, 2026 | Wednesday | Features
Physiotherapy is often limited by the availability of trained professionals, geographical barriers and the need for repeated in-person visits. Resolve360 is working to change this through a technology-enabled rehabilitation model that connects patients with licensed physiotherapists for personalised, one-on-one online care. Founded by Dr. Apoorva Shrivastava and Shivam Gupta, the company is combining clinical protocols, digital health tools and AI-powered movement analysis to make rehabilitation more accessible and scalable across geographies.
Problem
Access to quality physiotherapy remains uneven, particularly for patients in smaller cities and those requiring long-term rehabilitation. Conventional treatment can involve frequent clinic visits, travel expenses and limited continuity of care. Resolve360 aims to address these challenges through remote rehabilitation, personalised exercise programmes and technology-assisted patient monitoring.
Product
Resolve360 offers online one-on-one physiotherapy for musculoskeletal, neurological, paediatric and post-surgical conditions. Its platform combines live consultations with licensed physiotherapists, personalised rehabilitation protocols, progress tracking and care-manager support. The company is also developing AI and augmented reality (AR) technology that uses standard device cameras and motion-analysis algorithms to guide patients through therapeutic exercises.
Proof
Resolve360 reports supporting more than 50,000 patients and delivering over 20 lakh rehabilitation sessions across India and international markets. The company has also reported patent recognition for its methodology covering prognosis, protocol creation, delivery and execution for neuromuscular and musculoskeletal disorders.
People
Resolve360 was founded by Dr. Apoorva Shrivastava, Founder and CEO, and Shivam Gupta, Co-founder and CTO. Dr. Apoorva brings over 17 years of physiotherapy and rehabilitation experience, while Shivam leads product development, technology and go-to-market strategy.
Purse
On 6 August 2026, Kalaari Capital announced its investment in Resolve360 through its CXXO initiative. The investment amount was not publicly disclosed, with the capital intended to strengthen technology, expand the physiotherapist network and support customer acquisition.
Plan
Resolve360 aims to strengthen its digital rehabilitation platform through AI-enabled assessments, personalised treatment protocols and movement tracking. Its priorities include expanding its international patient base, growing its network of physiotherapists and scaling technology-assisted rehabilitation services.
Why it matters:
Resolve360 is addressing the accessibility and scalability challenges in rehabilitation through digital delivery and proprietary technology. By combining licensed physiotherapists with AI-assisted movement analysis and structured treatment protocols, the company is working towards making personalised rehabilitation more accessible across geographical boundaries.
FAST FACTS
|
Category
|
Details
|
|
Company
|
Resolve360
|
|
Legal entity
|
Rehabunified Private Limited
|
|
Incorporated
|
25 June 2021
|
|
Headquarters
|
Bengaluru, Karnataka
|
|
Founders
|
Dr. Apoorva Shrivastava and Shivam Gupta
|
|
Industry
|
HealthTech, Digital Rehabilitation, AI
|
|
Core offering
|
Online physiotherapy and rehabilitation
|
|
Key technology
|
AI-assisted movement analysis and patented rehabilitation methodology
|
|
Patent
|
Indian Patent No. 596041
|
|
Patent grant date
|
20 July 2026
|
|
Latest disclosed investment
|
Kalaari Capital, 6 August 2026
|
|
Reported patient reach
|
50,000+
|
|
Reported rehabilitation sessions
|
20 lakh+
|
|
International presence
|
65+ countries
|
|
Next
|
Expand AI-enabled rehabilitation, therapist network and international operations
|
Disclaimer: This profile is based on publicly available company information, official website disclosures, corporate records and investor announcements reviewed as of 4 November 2026.
